VTGN VISTAGEN THERAPEUTICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  9 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in VISTAGEN THERAPEUTICS INC (VTGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.46% (2024 Q1)
Avg. % of fund
1.55%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 616,749 -1,871,936 -75.2% 0.02% $142K $0.66
2025 Q3 ADDED 2,488,685 +75,431 +3.1% 1.55% $7.7M $3.55
2025 Q2 ADDED 2,413,254 +46,700 +2.0% 1.32% $4.1M $2.00
2025 Q1 ADDED 2,366,554 +38,062 +1.6% 1.63% $5.1M $2.50
2024 Q4 ADDED 2,328,492 +481,700 +26.1% 1.48% $5.9M $2.95
2024 Q3 REDUCED 1,846,792 -1,790 -0.1% 1.47% $4.9M $3.01
2024 Q2 UNCHANGED 1,848,582 0% 1.72% $5.8M $3.48
2024 Q1 ADDED 1,848,582 +58,400 +3.3% 2.46% $9.3M $5.28
2023 Q4 INITIATED 1,790,182 2.34% $8.8M
% of Fund (quarterly)    VTGN price (monthly, adj. close)
← Back to STEMPOINT CAPITAL LP Holdings